Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00118287 · COMPLETED

Trial details

NCT number: NCT00118287
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Secondary Myelodysplastic Syndromes

Start date: 2005-04-01
Primary completion: 2008-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.